{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:37:27Z","timestamp":1785458247940,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Food and Health Bureau","doi-asserted-by":"publisher","award":["COVID1903011"],"award-info":[{"award-number":["COVID1903011"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Food and Health Bureau","doi-asserted-by":"publisher","award":["COVID19F01"],"award-info":[{"award-number":["COVID19F01"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.eclinm.2023.102225","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T23:52:44Z","timestamp":1695167564000},"page":"102225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6275-1147","authenticated-orcid":false,"given":"Eric Yuk Fai","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Ka Chun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoey Cho Ting","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine Sze Ling","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-1959","authenticated-orcid":false,"given":"Francisco Tsz Tsun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-6071","authenticated-orcid":false,"given":"Carlos King Ho","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Fan Ngai","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chak Sing","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7602-9470","authenticated-orcid":false,"given":"Esther Wai Yin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eclinm.2023.102225_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.eclinm.2023.102225_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102225_bib3","series-title":"Therapeutic management of nonhospitalized adults with COVID-19","year":"2023"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102225_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/M22-3565","article-title":"Effectiveness of COVID-19 treatment with nirmatrelvir\u2013ritonavir or molnupiravir among U.S. veterans: target trial emulation studies with one-month and six-month outcomes","volume":"176","author":"Bajema","year":"2023","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102225_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/M22-3057","article-title":"Effectiveness of molnupiravir and nirmatrelvir\u2013ritonavir in hospitalized patients with COVID-19: a target trial emulation study","volume":"176","author":"Wan","year":"2023","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.eclinm.2023.102225_bib7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","article-title":"Real-world effectiveness of early molnupiravir or nirmatrelvir\u2013ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA. 2 wave: a retrospective cohort study","volume":"22","author":"Wong","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2023.102225_bib8","series-title":"Free COVID-19 oral drugs plan set","year":"2022"},{"key":"10.1016\/j.eclinm.2023.102225_bib9","series-title":"PAXLOVID\u2122 (nirmatrelvir tab; ritonavir tab)","year":"2022"},{"key":"10.1016\/j.eclinm.2023.102225_bib10","series-title":"Hong Kong\u2019s Hospital Authority expands use of Covid-19 oral drugs","author":"Ho","year":"2022"},{"key":"10.1016\/j.eclinm.2023.102225_bib11","first-page":"451","article-title":"Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","volume":"21","author":"Wan","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102225_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/cid\/ciab989","article-title":"Epidemiology of acute myocarditis\/pericarditis in Hong Kong adolescents following comirnaty vaccination","volume":"75","author":"Chua","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102225_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/annrheumdis-2021-221571","article-title":"Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong","volume":"81","author":"Li","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102225_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41467-022-28068-3","article-title":"Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong","volume":"13","author":"Lai","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102225_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M21-3700","article-title":"Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case\u2013control study","volume":"175","author":"Lai","year":"2022","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102225_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/joim.13453","article-title":"Post-Covid-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection","volume":"291","author":"Lai","year":"2022","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.eclinm.2023.102225_bib17","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1136\/gutjnl-2021-326860","article-title":"Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study","volume":"71","author":"Li","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.eclinm.2023.102225_bib18","article-title":"Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study","volume":"21","author":"Wan","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"10.1016\/j.eclinm.2023.102225_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/thy.2021.0684","article-title":"Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study","volume":"32","author":"Xiong","year":"2022","journal-title":"Thyroid"},{"issue":"15","key":"10.1016\/j.eclinm.2023.102225_bib20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMp2113319","article-title":"Methods of public health research\u2014strengthening causal inference from observational data","volume":"385","author":"Hern\u00e1n","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102225_bib21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease","volume":"19","author":"Hern\u00e1n","year":"2008","journal-title":"Epidemiology"},{"issue":"8","key":"10.1016\/j.eclinm.2023.102225_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eclinm.2023.102225_bib23","series-title":"Fact sheet for healthcare providers: emergency use authorization for Paxlovid","year":"2023"},{"key":"10.1016\/j.eclinm.2023.102225_bib24","series-title":"Fact sheet for healthcare providers: emergency use authorization for lagevrio (molnupiravir) capsules","year":"2023"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102225_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0962280211403603","article-title":"Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease","volume":"22","author":"Danaei","year":"2013","journal-title":"Stat Methods Med Res"},{"issue":"15","key":"10.1016\/j.eclinm.2023.102225_bib26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.eclinm.2023.102225_bib27","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.3748\/wjg.v25.i24.2990","article-title":"Application of big data analysis in gastrointestinal research","volume":"25","author":"Cheung","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102225_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"10373","key":"10.1016\/j.eclinm.2023.102225_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102225_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1473-3099(23)00118-4","article-title":"Effectiveness of nirmatrelvir\u2013ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system","volume":"23","author":"Lewnard","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102225_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1473-3099(23)00011-7","article-title":"Real-world use of nirmatrelvir\u2013ritonavir in outpatients with COVID-19 during the era of omicron variants including BA. 4 and BA. 5 in Colorado, USA: a retrospective cohort study","volume":"23","author":"Aggarwal","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eclinm.2023.102225_bib32","article-title":"Molnupiravir and risk of hospital admission or death in adults with Covid-19: emulation of a randomized target trial using electronic health records","volume":"380","author":"Xie","year":"2023","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102225_bib33","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100044","article-title":"Randomized trial of molnupiravir or placebo in patients hospitalized with Covid-19","volume":"1","author":"Arribas","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.eclinm.2023.102225_bib34","article-title":"Covid-19: what is the evidence for the antiviral Paxlovid?","volume":"377","author":"Extance","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2023.102225_bib35","article-title":"Covid-19: what is the evidence for the antiviral molnupiravir?","volume":"377","author":"Extance","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2023.102225_bib36","series-title":"Fact sheet for healthcare providers: emergency use authorization for Paxlovid","year":"2023"},{"issue":"17","key":"10.1016\/j.eclinm.2023.102225_bib37","first-page":"4980","article-title":"Predictors of long COVID in patients without comorbidities: data from the polish long-COVID cardiovascular (PoLoCOV-CVD) study","volume":"11","author":"Chudzik","year":"2022","journal-title":"J\u00a0Clin Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023004029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023004029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:02:19Z","timestamp":1778904139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023004029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":36,"alternative-id":["S2589537023004029"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102225","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102225"}}